jamunjar-logo
whatsapp
cartmembermenu
Search for
"test & packages"
"physiotherapy"
"heart"
"lungs"
"diabetes"
"kidney"
"liver"
"cancer"
"thyroid"
"bones"
"fever"
"vitamin"
"iron"
"HTN"

Culture & Sensitivity, Aerobic bacteria CSF( Vitek 2 Compact)

Bacterial/ Viral
image

Report in 72Hrs

image

At Home

nofastingrequire

No Fasting Required

Details

Identifies bacteria & antibiotic susceptibility.

1,0361,480

30% OFF

Culture & Sensitivity Aerobic bacteria CSF (Vitek 2 Compact)

  • Why is it done?
    • Identifies aerobic bacterial pathogens in cerebrospinal fluid (CSF) samples obtained through lumbar puncture or other invasive procedures
    • Diagnoses bacterial meningitis, encephalitis, and other CNS infections in patients presenting with fever, altered mental status, neck stiffness, and headache
    • Determines antibiotic susceptibility patterns to guide targeted antimicrobial therapy and prevent empiric overtreatment
    • Monitors treatment efficacy in patients with documented bacterial CNS infections
    • Performed urgently when meningitis is suspected, typically within hours of hospitalization as bacterial CNS infections are medical emergencies requiring immediate intervention
    • Used as adjunct to gram stain microscopy for confirmation and definitive organism identification
  • Normal Range
    • Normal/Negative Result: No growth of aerobic bacteria after 24-48 hours of incubation
    • Units of Measurement: Colony-forming units per milliliter (CFU/mL) or qualitative presence/absence
    • Negative CSF Culture: Indicates absence of aerobic bacterial infection; patient likely has viral meningitis, aseptic meningitis, or non-infectious etiology
    • Positive CSF Culture: Growth of pathogenic aerobic bacteria (any growth is typically considered clinically significant given the sterile nature of CSF compartment); organism identification and susceptibility results reported
    • Borderline/Contamination: Growth of skin commensals (Coagulase-negative Staphylococcus, Corynebacterium, Bacillus) may represent contamination; clinical correlation required to distinguish from true infection
  • Interpretation
    • Positive Culture Results:
    • Confirms bacterial meningitis or other acute bacterial CNS infection requiring immediate antimicrobial intervention
    • Common aerobic pathogens identified include: Neisseria meningitidis, Streptococcus pneumoniae, Listeria monocytogenes, Gram-negative rods (E. coli, Klebsiella, Pseudomonas aeruginosa), Haemophilus influenzae
    • Susceptibility testing results indicate which antibiotics are effective; reported as susceptible, intermediate, or resistant categories
    • Vitek 2 Compact provides rapid identification through automated biochemical analysis and antibiotic susceptibility profiling, typically within 18-24 hours
    • Negative Culture Results:
    • Excludes bacterial etiology; however, does not rule out bacterial infection if obtained after antibiotic administration
    • Suggests viral meningitis, aseptic meningitis, fungal infection, tuberculosis, or non-infectious inflammatory conditions; must correlate with CSF cell counts, protein, glucose, and clinical presentation
    • Factors Affecting Results:
    • Prior antibiotic administration decreases culture sensitivity; ideally obtain CSF before antibiotics or acknowledge timing in clinical interpretation
    • Specimen contamination during collection or processing may result in false positives from skin flora
    • Delayed transport or improper storage may reduce organism viability and culture sensitivity
    • Low bacterial burden in early infection or partially treated meningitis may result in negative cultures despite active bacterial disease
    • Fastidious organisms or those with special growth requirements may require extended incubation or special media not routinely used
  • Associated Organs
    • Primary Organ Systems:
    • Central Nervous System (CNS): Brain and spinal cord; specifically evaluates meninges inflammation and parenchymal infection
    • Peripheral Immune System: Response to CNS infection affects systemic immune activation and inflammatory markers
    • Conditions Associated with Abnormal Results:
    • Acute Bacterial Meningitis: Life-threatening infection of meningeal membranes; medical emergency with high mortality and morbidity if untreated
    • Bacterial Encephalitis: Direct bacterial invasion of brain parenchyma causing altered mental status, seizures, and neurological complications
    • Ventriculitis: Bacterial infection of ventricular system; often associated with shunts, drains, or post-neurosurgical procedures
    • Subdural Empyema: Bacterial collection between dura and arachnoid; requires urgent surgical intervention
    • Post-Neurosurgical Infection: Bacterial contamination following craniotomy, shunt placement, or invasive neurological procedures
    • Immunocompromised Patients: Higher susceptibility to atypical or opportunistic bacterial pathogens
    • Potential Complications of Untreated Bacterial CNS Infection:
    • Permanent neurological sequelae: Hearing loss, cognitive impairment, motor deficits, seizures
    • Hydrocephalus: Impaired CSF flow requiring ventriculoperitoneal shunt placement
    • Sepsis and septic shock: Progression to systemic infection with multiorgan failure
    • Death: Mortality rates 15-25% for meningococcal meningitis and 20-30% for pneumococcal meningitis if untreated
  • Follow-up Tests
    • Recommended Follow-up Based on Positive Culture:
    • Repeat CSF Culture: Typically performed 24-48 hours after initiation of antibiotics to document sterilization and treatment efficacy; may be repeated if clinical deterioration occurs
    • Blood Cultures: Obtained simultaneously with CSF; may identify same organism supporting diagnosis and assessing bacteremia severity
    • CSF Cell Count and Differential: Determines inflammatory profile; lymphocytic vs neutrophilic predominance guides diagnostic consideration
    • CSF Chemistry: Glucose and protein levels corroborate bacterial infection diagnosis; low glucose with elevated protein characteristic of bacterial meningitis
    • CSF Gram Stain: Rapid presumptive organism identification; guides initial empiric therapy while awaiting culture results
    • PCR Molecular Testing: Rapid detection of common meningitis pathogens (meningococcus, pneumococcus, H. influenzae) if available; supplements culture
    • Associated Imaging and Diagnostic Studies:
    • Brain MRI: Evaluates for complications including subdural empyema, ventriculitis, abscess formation, or cerebritis
    • Head CT: Initial imaging to exclude contraindications to lumbar puncture or identify mass effect and increased intracranial pressure
    • Laboratory Monitoring:
    • Complete Blood Count: Assess for leukocytosis or leukopenia indicating severity of systemic response
    • Procalcitonin and C-Reactive Protein: Measure inflammatory response and monitor treatment response; trending decreases indicate clinical improvement
    • Blood Chemistry: Electrolytes, renal function, liver function to assess complications and drug toxicity from prolonged antibiotic therapy
    • Audiometry: Recommended follow-up 2-4 weeks post-infection to detect sensorineural hearing loss from meningitis
    • Monitoring Frequency:
    • Clinical assessment every 6-12 hours during acute phase with documented meningitis
    • Repeat CSF studies at 24-48 hours for positive initial culture to confirm sterilization
    • Long-term neurological follow-up at 1 month and 3 months post-discharge to assess for sequelae
  • Fasting Required?
    • Fasting Required: No
    • CSF cultures are obtained by lumbar puncture and are not affected by fasting status; no dietary restrictions necessary
    • Patient Preparation Requirements:
    • Informed Consent: Obtain consent for lumbar puncture procedure including explanation of risks (headache, infection, bleeding, neurological complications)
    • Contraindication Assessment: Evaluate for mass lesions, papilledema, coagulopathy, or platelet dysfunction before lumbar puncture
    • Positioning: Patient positioned in lateral decubitus position (side-lying) with knees flexed to chest or seated with chest flexed forward
    • Bladder Emptying: Patient should void before procedure for comfort and accuracy of opening CSF pressure measurement
    • Medications:
    • Anticoagulants and Antiplatelet Agents: Ideally discontinued or held before lumbar puncture to reduce bleeding risk; coordinate timing with clinical urgency
    • Sedatives/Anesthetics: May be administered for patient comfort; local anesthesia at puncture site standard
    • Antibiotics: In meningitis suspected patients, initiate empiric antibiotics before or concurrent with lumbar puncture; do not delay therapy for culture
    • Specimen Collection and Handling:
    • Sterile Technique: Strict aseptic technique mandatory; use sterile needles and collection tubes; decontaminate skin with chlorhexidine or iodine-based antiseptic
    • Tube Collection: Typically collect 3 mL CSF in sterile, sterile tube (usually tube #3 or final tube) for culture to minimize contamination
    • Immediate Transport: Transport specimen to microbiology laboratory immediately; do not refrigerate; maintain room temperature to preserve organism viability
    • Processing: Should be processed within 1 hour of collection for optimal yield; stat processing required for suspected meningitis

How our test process works!

customers
customers